tiprankstipranks
Trending News
More News >
Pacira (PCRX)
:PCRX
US Market
Advertisement

Pacira Pharmaceuticals (PCRX) Technical Analysis

Compare
373 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
5Neutral
6Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Pacira’s (PCRX) Moving Averages Convergence Divergence (MACD) indicator is 0.16, suggesting Pacira is a Sell.
Pacira’s (PCRX) 20-Day exponential moving average is 23.23, while Pacira’s (PCRX) share price is $21.85, making it a Buy.
Pacira’s (PCRX) 50-Day exponential moving average is 23.43, while Pacira’s (PCRX) share price is $21.85, making it a Buy.

Pacira Pharmaceuticals (PCRX) Pivot Points

Nov 30, 2025, 02:47 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
22.20
22.67
23.24
23.71
24.28
24.75
25.32
Fibonacci
22.67
23.07
23.31
23.71
24.11
24.35
24.75
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Pacira Pharmaceuticals (PCRX) Moving Averages

Nov 30, 2025, 02:47 AM
Period
Simple
Exponential
MA5
23.35Buy
23.50Buy
MA10
23.59Sell
23.42Buy
MA20
23.08Buy
23.23Buy
MA50
23.38Buy
23.43Buy
MA100
23.94Sell
23.76Sell
MA200
24.38Sell
23.68Sell
Pacira’s (PCRX) 10-Day exponential moving average is 23.42, while Pacira’s (PCRX) share price is $21.85, making it a Buy.
Pacira’s (PCRX) 100-Day exponential moving average is 23.76, while Pacira’s (PCRX) share price is $21.85, making it a Sell.
Pacira’s (PCRX) stock price is $21.85 and Pacira’s (PCRX) 50-day simple moving average is 23.38, creating a Buy signal.
Pacira’s (PCRX) stock price is $21.85 and Pacira’s (PCRX) 100-day simple moving average is 23.94, creating a Sell signal.
Pacira’s (PCRX) stock price is $21.85 and Pacira’s (PCRX) 200-day simple moving average is 24.38, creating a Sell signal.

Pacira Pharmaceuticals (PCRX) Technical Indicators

Nov 30, 2025, 02:47 AM
Name
Value
Implied Action
RSI (14)
53.22
Neutral
STOCH (9,6)
46.12
Neutral
STOCHRSI (14)
64.93
Neutral
MACD (12,26)
0.16
Sell
ADX (14)
19.97
Buy
Williams %R
-42.14
Buy
CCI (14)
58.08
Neutral
ATR (14)
1.11
-
Ultimate Oscillator
42.42
Neutral
ROC
6.89
Buy
Pacira’s (PCRX) Relative Strength Index (RSI) is 53.22, creating a Neutral signal.
Pacira’s (PCRX) Trend Strength Indicator (ADX) is 19.97, creating a Buy signal.
Pacira’s (PCRX) Commodity Channel Index (CCI) is 58.08, creating a Neutral signal.
Pacira’s (PCRX) Price Rate of Change (ROC) is 6.89, creating a Buy signal.

FAQ

Is PCRX a Buy, Hold, or Sell?
Based on PCRX’s technical indicators, PCRX is a Buy.
    What is PCRX’s RSI (14)?
    PCRX’s RSI (14) is 53.22, which suggests PCRX is a Neutral.
      What is PCRX’s MACD?
      PCRX’s MACD is 0.16, which suggests PCRX is a Sell.
        What is PCRX’s 5-day moving average?
        PCRX’s 5-day moving average is 23.35, which suggests PCRX is a Buy.
          What is PCRX’s 20-day moving average?
          PCRX 20-day moving average is 23.08, which suggests PCRX is a Buy.
            What is PCRX’s 50-day moving average?
            PCRX’s 50-day moving average is 23.38, which suggests PCRX is a Buy.
              What is PCRX’s 200-day moving average?
              PCRX’s 200-day moving average is 24.38, which suggests PCRX is a Sell.
                What is PCRX’s Williams % R (14)?
                PCRX’s Williams % R (14) is -42.14, which suggests PCRX is a Buy.
                  What is PCRX’s CCI (14)?
                  PCRX’s CCI (14) is 58.08, which suggests PCRX is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis